IDH Mutations, MGMT Methylation and 1p/19q Status Provides Better Diagnosis and Survival Prediction in an Indian Cohort of Diffuse Gliomas

被引：0
|
作者：
Majumdar, A. [1 ]
Katara, R. [1 ]
Bhardwaj, M. [1 ]
Verma, A. [1 ]
Sharma, D. K. [1 ]
Kumar, S. [1 ]
Kini, L. [1 ]
Pandita, A. [1 ]
Singh, R. [2 ]
机构：
[1] CORE Diagnost, Gurgaon, India
[2] Artemis Hosp, Gurgaon, India
来源：
JOURNAL OF MOLECULAR DIAGNOSTICS | 2019年 / 21卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
ST019
引用
收藏
页码：1188 / 1188
页数：1
相关论文
共 50 条
  • [1] Impact of MGMT methylation status on 1p/19q intact anaplastic gliomas
    Franceschi, E.
    Tosoni, A.
    Ermani, M.
    Spagnolli, F.
    La Torre, L.
    Galzio, R. J.
    Pozzati, E.
    Talacchi, A.
    Benevento, F.
    Brandes, A. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [2] MGMT promoter methylation is associated with patient age and 1p/19q status in IDH-mutant gliomas
    Horbinski, Craig
    McCortney, Kathleen
    Stupp, Roger
    NEURO-ONCOLOGY, 2021, 23 (05) : 858 - 860
  • [3] Survival Risk Prediction Models of Gliomas Based on IDH and 1p/19q
    Zou, Han
    Li, Chang
    Wanggou, Siyi
    Li, Xuejun
    JOURNAL OF CANCER, 2020, 11 (15): : 4297 - 4307
  • [4] PROGNOSTIC VALUE OF MGMT METHYLATION STATUS IN PATIENTS WITH 1P/19Q INTACT ANAPLASTIC GLIOMAS
    Franceschi, Enrico
    Tosoni, Alicia
    Ermani, Mario
    Sturiale, Carmelo
    Dall'Occa, Patrizia
    Pession, Annalisa
    Di Oto, Enrico
    Morandi, Luca
    Bartolini, Stefania
    Brandes, Alba A.
    ANNALS OF ONCOLOGY, 2009, 20
  • [5] IDH1 MUTATIONS WITH RELEVANCE TO 1P/19Q LOSS AND MGMT METHYLATION IN PEDIATRIC GLIOMA PATIENTS
    Adachi, J.
    Suzuki, T.
    Yanagisawa, T.
    Mishima, K.
    Fukuoka, K.
    Koga, T.
    Matsutani, M.
    Nishikawa, R.
    NEURO-ONCOLOGY, 2012, 14 : 66 - 66
  • [6] IDH2 mutations are commonly associated with 1p/19q codeletion in diffuse adult gliomas
    Appay, Romain
    Tabouret, Emeline
    Macagno, Nicolas
    Touat, Mehdi
    Carpentier, Catherine
    Colin, Carole
    Ducray, Francois
    Idbaih, Ahmed
    Mokhtari, Karima
    Uro-Coste, Emmanuelle
    Dehais, Caroline
    Figarella-Branger, Dominique
    NEURO-ONCOLOGY, 2018, 20 (05) : 716 - 718
  • [7] Frequency of MGMT Promoter Hypermethylation, 1p/19q Co-Deletions and IDH1 and IDH2 Mutations in Gliomas
    Shajani-Yi, Z.
    Nguyen, L. N.
    Hickey, W. F.
    Deharvengt, S. J.
    de Abreu, F. Blumental
    Peterson, J. D.
    Gallagher, T. L.
    Erskine, A. J.
    Lefferts, J. A.
    Tsongalis, G.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2016, 18 (06): : 1023 - 1023
  • [8] NATIONAL EPIDEMIOLOGY AND SURVIVAL OF ADULT-TYPE DIFFUSE GLIOMAS IN THE UNITED STATES BY IDH, 1P/19Q, MGMT, AND WHO CNS GRADE
    Iorgulescu, Bryan
    Sun, Chuxuan
    Cioffi, Gino
    Neff, Corey
    Shoaf, Madison
    Waite, Kristin
    Kruchko, Carol
    Wen, Patrick Y.
    Brat, Daniel
    Ostrom, Quinn
    Barnholtz-Sloan, Jill
    NEURO-ONCOLOGY, 2022, 24 : 111 - 112
  • [9] Impact of IDH Mutations, the 1p/19q Co-Deletion and the G-CIMP Status on Alternative Splicing in Diffuse Gliomas
    Zhang, Lu
    Fritah, Sabrina
    Nazarov, Petr V.
    Kaoma, Tony
    Van Dyck, Eric
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (12)
  • [10] MGMT methylation status does not provide adjunctive prognostic information in pts with 1p/19q intact anaplastic gliomas
    Franceschi, E.
    Tosoni, A.
    Ermani, M.
    Spagnolli, F.
    La Torre, L.
    Tomasello, C.
    Bacci, A.
    Morandi, L.
    Mazzocchi, V.
    Brandes, A. A.
    EJC SUPPLEMENTS, 2009, 7 (02): : 500 - 500
12345